Collectively, quercetin demonstrates synergistic activity against colorectal cancer through concurrent suppression of inflammatory mediators (TNF-α→COX-2/iNOS axis) and oxidative effectors (LPO/NO/G6PD). The gene discussed is NOS2; the disease is colorectal cancer.